Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
MBMA Bridging Models as a Tool for Exploration of Clinical Endpoints in Unstudied Indications.
Journal: CPT: pharmacometrics & systems pharmacology
Published: July 30, 2025
A randomised phase II study evaluating the efficacy and safety of subcutaneously administered ustekinumab and guselkumab in patients with active rheumatoid arthritis despite treatment with methotrexate.
Journal: Annals of the rheumatic diseases
Published: May 03, 2016
Radiographic Progression of Patients With Psoriatic Arthritis Who Achieve Minimal Disease Activity in Response to Golimumab Therapy: Results Through 5 Years of a Randomized, Placebo-Controlled Study.
Journal: Arthritis care & research
Published: November 20, 2014
Clinical efficacy, radiographic and safety findings through 5 years of subcutaneous golimumab treatment in patients with active psoriatic arthritis: results from a long-term extension of a randomised, placebo-controlled trial (the GO-REVEAL study).
Journal: Annals of the rheumatic diseases
Published: April 22, 2014
The effect of two golimumab doses on radiographic progression in ankylosing spondylitis: results through 4 years of the GO-RAISE trial.
Journal: Annals of the rheumatic diseases
Published: May 07, 2013
Patient-reported outcomes and the association with clinical response in patients with active psoriatic arthritis treated with golimumab: findings through 2 years of a phase III, multicenter, randomized, double-blind, placebo-controlled trial.
Journal: Arthritis care & research
Published: January 02, 2013
Clinical efficacy, radiographic and safety findings through 2 years of golimumab treatment in patients with active psoriatic arthritis: results from a long-term extension of the randomised, placebo-controlled GO-REVEAL study.
Journal: Annals of the rheumatic diseases
Published: November 20, 2012
Markers of inflammation and bone remodelling associated with improvement in clinical response measures in psoriatic arthritis patients treated with golimumab.
Journal: Annals of the rheumatic diseases
Published: September 15, 2012
Golimumab in psoriatic arthritis: one-year clinical efficacy, radiographic, and safety results from a phase III, randomized, placebo-controlled trial.
Journal: Arthritis and rheumatism
Published: March 02, 2012
Comprehensive tuberculosis screening program in patients with inflammatory arthritides treated with golimumab, a human anti-tumor necrosis factor antibody, in Phase III clinical trials.
Journal: Arthritis care & research
Published: February 07, 2012
Interferon-γ release assay versus tuberculin skin test prior to treatment with golimumab, a human anti-tumor necrosis factor antibody, in patients with rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitis.
Journal: Arthritis and rheumatism
Published: January 13, 2012
Showing 1-11 of 11
Last Updated: 09/26/2026